CA
CA · CA · CA-DIN-02503778
OCTREOTIDE FOR INJECTABLE SUSPENSION
ATC H01CB02
Last synced from Health Canada Drug Product Database (Canada) on
Identification
ManufacturerTEVA CANADA LIMITED
CountryCA (CA)
ATC codeH01CB02
Dispensing—
ReimbursedNo
SourceHealth Canada Drug Product Database (Canada)
Last synced6/11/2026
Packs · 0
No packs registered.
Annotations
No annotations yet.
Raw payload (JSON)
{
"din": "02503778",
"form": "POWDER FOR SUSPENSION, SUSTAINED-RELEASE",
"class": "Human",
"routes": [
"INTRAMUSCULAR"
],
"source": "health_canada_dpd",
"status": "MARKETED",
"atc_raw": "H01CB02",
"schedule": [
"Prescription"
],
"drug_code": "99321",
"strengths": [
"20 MG"
],
"ahfs_class": null,
"substances": [
"OCTREOTIDE (OCTREOTIDE ACETATE)"
],
"product_categorization": null
}Related drugs
Other records sharing ATC code H01CB02.
- 🇺🇸BYNFEZIA PenSun Pharmaceutical Industries, Inc.
- IEEzetimibe/Simvastatin Teva Pharma 10 mg/20 mg tabletsTeva B.V.
- IEEzetimibe/Simvastatin Teva Pharma 10 mg/80 mg tabletsTeva B.V.
- FIMycapssaAmryt Pharmaceuticals DAC
- PLMycapssaAmryt Pharmaceuticals DAC
- DKMycapssaAmryt Pharmaceuticals DAC
- 🇺🇸MycapssaChiesi USA, Inc.
- 🇺🇸MycapssaAmryt Pharmaceuticals Designated Activity Company
Access this data programmatically
Query OCTREOTIDE FOR INJECTABLE SUSPENSION and 610,000+ other drug records through a single REST API — with a last_synced_at provenance stamp on every response. Free tier includes 100 requests/day.